ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Vivos Inc (QB)

Vivos Inc (QB) (RDGL)

0.12992
-0.00008
(-0.06%)
Closed February 08 3:00PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

RDGL News

Official News Only

RDGL Discussion

View Posts
WALLnut WALLnut 2 hours ago
Well, now you know.


RDGL
👍 2
TurningPoint TurningPoint 4 hours ago
What ????
   Everybody gives the different meaning in other words you're version of what spam is.
  I have been here on ihub for more than six years.
  In any bo I have been here on ihop. I havI evvvv been hereard when someone   I have been here on ihub for more than six years.
    That is your version of Spam. I've never seen that before. In six years in
Many other boards that I have been in. 
Sharing with a board new technologies
Aa and new advancements in the same field. Add new advances in the same field Has always been welcomed in all the other boards that I have done it in the past.
    This is the first time anyone has given it a definition of spam
👍️0
WALLnut WALLnut 4 hours ago
Vivos has filed patent restrictions in many countries. That's a good thing and a great sign.




RDGL
👍️ 2
Augster Augster 5 hours ago
Vivos filed a patent in South Korea, that was posted several months back.
👍️0
WALLnut WALLnut 5 hours ago
Your posts represent other companies potential cancer cures. That's considered spam.



RDGL
👍️0
TurningPoint TurningPoint 5 hours ago
Why are my posts being deleted ???

There are fraudsters in these boards
They're post don't get deleted.
I am posting a recent development in the cure of cancer. 🤷‍♂️
👍️0
WALLnut WALLnut 18 hours ago
You’re deliberately twisting the facts again. First, let’s be clear—Vivos has been working with the FDA for years, refining their submission based on direct feedback. Sprint discussions and withdrawn applications absolutely do count because they shape the final IDE submission. That’s how regulatory approvals work.

If the FDA needed more safety data before accepting an IDE, then gathering and providing that data is the correct process. The fact that Vivos is still engaged with the FDA means they are working toward an IDE that will be approved, not just submitted for the sake of saying it was.

The real question is, why are you so obsessed with pushing this ‘never submitted’ narrative when the process clearly involves ongoing FDA interactions? Either you don’t understand how regulatory approvals work, or you do—and you’re just trying to mislead people.


RDGL
👍️ 4
WALLnut WALLnut 18 hours ago
You keep repeating the same tired narrative without understanding how the FDA process works. MK’s 45-day statement was based on the FDA’s feedback at that time. But here’s what you ignore—when the FDA requests additional data or meetings, that takes priority over submission. That’s not lying or incompetence; that’s following the regulatory process.

And let’s be real: if MK were ‘incompetent,’ the FDA wouldn’t still be engaged with Vivos. They don’t waste time on companies they don’t take seriously. The fact that sprint discussions are happening shows the FDA wants this done right, not rushed.

So, instead of pushing a false narrative, try keeping up with reality. The FDA—not MK—controls the timeline, and every step Vivos takes is based on FDA requirements, not your personal impatience.


RDGL
👍️ 1
Pop23 Pop23 19 hours ago
https://img1.wsimg.com/isteam/ip/12728d41-fabf-4513-a74f-ba9f1951d7ff/Jan%207%202025.png/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:806,cg:true
👍️ 1
Big Al T Big Al T 19 hours ago
EXACTLY!!!!
👍️ 1
halldorson halldorson 20 hours ago
Why don t you ALL put SC8 on ignore like I did and force him to create a new screen name at the very least. Then we can compare his vocabulary, sentence structure and keep doing it. Nothing better than cancel culture to make this board a little more amusing. Who is the greater fool - the fool or the person who argues with the fool? Come on people put SC8 on ignore!
👍️ 3
SC8 SC8 20 hours ago
What's this resubmitting nonsense? He first has to submit an IDE application, which he hasn't done yet, not once in a nearly a decade running RDGL. Withdrawn applications don't count.
👍️0
SC8 SC8 20 hours ago
Please, it was very clear MK said submission in 45 days after he withdrew the fubared application. He's either a liar, completely incompetent or both. I say both.
👍️0
WALLnut WALLnut 20 hours ago
Your argument falls apart when you actually understand how the FDA works. Sprint meetings aren’t scheduled by MK or Vivos—they’re scheduled by the FDA. The timing of each meeting is entirely up to them, not some imaginary delay tactic.

And let’s talk about your ‘final sprint meetings’ claim. If you actually followed regulatory processes, you’d know that multiple sprint discussions are common for new technologies like RadioGel. Each one addresses specific issues until everything is aligned for approval. The fact that the FDA is still engaging means the process is moving forward—not stalled.

As for your '45-day' argument, that referred to a specific step in the process, not an immediate guarantee of submission. Regulatory pathways take time, especially for a novel therapy.

So instead of trying to twist reality, maybe try understanding it first. The FDA controls the schedule, not MK, and every sprint meeting is a step closer to approval.


RDGL
👍️ 4
mikepgator mikepgator 21 hours ago
For as much as you’re on this board, I can’t believe you’re not following along. The FDA needed more safety data before resubmitting, get with the program.
👍️0
SC8 SC8 21 hours ago
How many of these endless "final Sprint meetings" have there been now? When did he say submission is 45 days? Back in July? Sad how people hang on this liar's every word.
👍️0
stocup stocup 21 hours ago
I see there’s been no response to this, wonder why?
👍️0
CatfishHunter CatfishHunter 22 hours ago
Well, hopefully you haven't sold all your shares yet. It's just starting to get really good.
👍 1
rogers711 rogers711 23 hours ago
They had a timeline for the sprint meetings as well and look what happened there... 
👍 1
mikepgator mikepgator 23 hours ago
Once Vivos resubmits the IDE they will have gotten the “nod” from the FDA, so there will be a high probability of approval, stock will start moving to .30-.50 range.
👍️ 2
konshe konshe 23 hours ago
If FDA agree RDGL to re-submitting IDE at final meeting on 02/19/2025, then it will be approved is confirmed too. March Is interesting month,see PPS going up to dollars area.
👍 1
mikepgator mikepgator 1 day ago
We are back to having a timeline, we were stuck with one for a while and that didn’t help the stock price. It should start moving up in the next few weeks.
👍 2
CatfishHunter CatfishHunter 1 day ago
And yet they don't report that in their major media releases.  Because it's not actually happening.  "They claim"...what a joke. BetaScam! 
👍 1
Roofus Roofus 1 day ago
I’m guessing early March is when they’re targeting IDE submission.

Maybe get approval by the end of March?
That’s only about 7 weeks away.
👍️ 2 😁 1
Roofus Roofus 1 day ago
He certainly wasn’t working overtime at Vivos.

Or anything worthwhile to be retained as an employee, lol.
👍️0
Gobsmacked01 Gobsmacked01 1 day ago
Looks like Dr. K will be conducting human trials in parallel India AND America domestically... as he said he would!

How incompetent does a crew have to be to claim our nearest competitor is hugely staffed, extremely well paid, has been injecting humans waaaay longer and yet can't get their product in a human outside of Europe and can't link anywhere that any human or animal tumor was ever reduced by 80%?

No competition at all, imho.

-Go $RDGL
👍️0
doccjc doccjc 1 day ago
Final Sprint meeting is next week and a meeting is scheduled with the FDA on February 19th. The IDE submission must be getting close.
👍️ 4 💥 1
AtlasQ AtlasQ 1 day ago
https://x.com/radiogel/status/1887909795354808332?s=46
👍️ 2
chereb19 chereb19 1 day ago
Why don't you link the trials from a clinical trial register? Because it doesn't exist
👍️0
chereb19 chereb19 1 day ago
They aren't even in phase 1.

Not a single shred of evidence of any clinical trials registered
👍️0
chereb19 chereb19 1 day ago
Criticizing an 80% tumor size reduction as a failure in a Phase 1 trial completely misinterprets the trial's purpose. In fact, achieving any significant tumor shrinkage in this early stage is an unexpected and promising outcome, not a failure. “the primary intent of Phase 1 studies is not to demonstrate therapeutic benefit” (Guidance for Industry: Cancer Clinical Trial Eligibility Criteria).
👍️0
chereb19 chereb19 1 day ago
Fake news. I tried the website and it doesn't work
👍️0
Truthsocial Truthsocial 1 day ago
I'm thinking maybe a Valentines day massacre of the remaining non RDGL competitors that will never compete with
RDGL AND ISOPET

All imo
👍️0
SC8 SC8 1 day ago
Of course they're not messing with FDA yet. They're a European company trialing their product in Europe. To do a USA trial, they'd have to set up supply chain and manufacturing here first as Y90 only has a 2.7 day half life. They have no reason whatsoever to be messing with FDA now. That would be a worse misallocation of resources than MK's pet project is
👍️0
SC8 SC8 1 day ago
Thank you for confirming this RDGL clinic trial is treating tumors that had already spread from elsewhere to lymph nodes. So odds of these patients getting any long term benefit from Radiogel treatment is slim to none. Many here condemned me for stating that was likely the case cuz the tumors were in the lymph nodes. Now we know that is indeed the case. Sad for these patients.
👍️0
SC8 SC8 1 day ago
Never claimed the RDGL competitor was in phase 3 trials.
👍️0
SC8 SC8 1 day ago
Please, no safety claims can be made in absence of Radiogel dosing sufficient to kill treated tumor. The only anecdote we have from MK is at 30 days a portion of tumor in one patient survived treatment. We have no idea what's going on with the other 4 patients. Those are the facts at hand. Anything else is speculation.
👍️0
Gobsmacked01 Gobsmacked01 1 day ago
Are they too incompetent to post their FDA Genotoxicity test outcome acceptance?

In all their many years of gluing humans to marbles, did ANY tumor reduce in size by 80%?

Are there before and after tumor reduction plates? I'm thinking say a tumor treated of the cancer on the spleen of a tiny lab mouse? The RDGL video is still up on youtube...

RDGL is killing it in a Class all their own, imho!

-Go $RDGL
👍️0
SC8 SC8 1 day ago
Again, I can stipulate to 30 day scan showing cancer survived treatment not being a verdict on Radiogel yet. So why are MK and his sycophants declaring proof of safety and efficacy when neither is the case yet? I, on the other hand, am just sticking with the facts at hand.

On the market, the fact MK hasn't closed the offering yet is proof buyers aren't banging down his door for those cheap shares that come with warrants. The low volume atm is proof new buyers aren't putting in big orders there either. It is what it is and doesn't look good. IMO this is the consequence of MK lying too many times about too many things to too many people.
👍️0
SC8 SC8 1 day ago
They claim several liver and breast cancer patients. They're far better funded than RDGL with investors on the BOD and are 2.5 years ahead in clinical trials.
👍️0
BBANBOB BBANBOB 1 day ago
Nopey but all it takes is one whale and we have all seen that happen
👍️0
mikepgator mikepgator 1 day ago
The primary focus of this trial is safety, and getting the data required by the FDA to resubmit the IDE application. All this talk from SC8 is nonsense.


Public Title of Study:
Testing the Safety of a gel-based radiotherapy treatment for cancer that has spread into the lymph nodes.

Scientific Title of Study:
A Study of the Safety of RadioGel (Yttrium-90 Phosphate suspended within a Hydrogel Delivery Vehicle) as Brachytherapy Device for the treatment of any solid recurrent or metastatic tumors involving the lymph nodes associated with cancer, accessible by percutaneous direct needle injection. A Phase 1 Study

Primary Outcome:
The occurrence of adverse events will be used to determine the safety of RadioGel. The determination of adverse events will be based on in-person evaluation by the treating physician and verbal reports from the patient whenever an in-person, virtual or telephone contact is established. Symptoms related to nerve function (such as new development of hoarseness), dysphagia, odynophagia, of vascular injury will be evaluated to determine if related to the brachytherapy and clinical adverse events to be recorded include local pain, local infection, persistent skin erythema or ulceration, injury to larynx or esophagus, nerve dysfunction as manifested by voice dysfunction after 24 hours (to account for local anesthetic effect), vascular injury, hemorrhage, development of abnormal fluid collections, venous thrombosis, neuropathic symptoms, aspiration, laryngeal dysfunction, and dysphagia.
👍️0
rogers711 rogers711 1 day ago
This volume we aren't coming anywhere near it, this is disgusting... 
👍️0
BBANBOB BBANBOB 1 day ago
It is what the second or is this the third day since the news, and I WILL always hang with that it takes 2- 3-4 days for news to disseminate and be digested
👍️0
Truthsocial Truthsocial 1 day ago
The day is young ....patience for RDGL AND ISOPET
👍️0
BBANBOB BBANBOB 1 day ago
Well short of a miracle it doesn't look like we are gonna hit my prediction of 15-18 by FRIDAY, lol there will be another FRI we will be there imho
👍️0
BBANBOB BBANBOB 1 day ago
WALnut
I appreciate your stance and concern over misinformation but having been in the markets for some 50 yrs, I have found that message board chatter really doesn't direct or control the value of a stock.
THE STOCK and its performance in it's specific industry does.

IN short the success of a company and it's product control the PPS.
If IF IFIN it is effective and works, those involved in the project DR's, Nurses, Clinical help start telling friends, then the milk man, barber, UPS driver ect ect ect

I have already directed several here, I directed one here that, IF IF IFIN he came to play here he has the ability to drive this way north based just on his financial ability to buy a literal ton of shares,like the daily vol on a whim

And like you Thank for the civility in your response and I hope your long wait pays of well for you

GLTY and to all here
👍️ 1
mikepgator mikepgator 1 day ago
Betaglue worst name ever. If I have the option of Radiogel or Betaglue injection, I’m choosing Radiogel every time.
👍️ 1
CatfishHunter CatfishHunter 1 day ago
Fake news. If they were, they would have more documented patients. Not just the initial single patient from 2022.  It's a scam. Betaglue it BetaScam.  Shameful. 
👍️0
Gobsmacked01 Gobsmacked01 1 day ago
Isopet provides us the advantage of anecdotal comparison to our clinical trial patient. Our possible Class II brachytherapy for humans has an animal treatment history treating tumors on creatures as small as a ferret and as large as a horse WITH PICTURES, lol.

30 days out, of course the radiation is gone and has been for weeks, but the gel is seen still dissolving, releasing destroyed tumor cells for resorption, and reducing the tumor footprint size. Overtime only a minimal site indication remains if any.

Does a Class III more dangerous device deliver the same 80% tumor reduction in 30 days? Not if the glue holds, otherwise it has released a LOT of glass or resin beads into the patient potentially causing organ harm.

Isopet rules! RDGL is showing results! The rest is just waiting, imho.

-Go $RDGL
👍️0

Your Recent History

Delayed Upgrade Clock